COCH · NASDAQ
Envoy Medical (COCH) Stock Price & Fundamentals
Envoy Medical (COCH) closed at $590.53 on Oct 9, 2026, up 0.04% from the previous close of $590.30.
Share price, past year
1Y +30.55%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $590.53 |
| Sep 30, 2026 | $583.33 |
| Aug 31, 2026 | $608.73 |
| Jul 31, 2026 | $584.82 |
| Jun 30, 2026 | $619.52 |
| May 29, 2026 | $607.24 |
| Apr 30, 2026 | $589.70 |
| Mar 31, 2026 | $569.66 |
| Feb 27, 2026 | $566.92 |
| Jan 30, 2026 | $522.66 |
| Dec 31, 2025 | $469.93 |
| Nov 28, 2025 | $499.88 |
| Oct 31, 2025 | $460.71 |
Key statistics
- Market cap
- $12.71B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $207.00K
- Net income (TTM)
- −$23.40M
- Shares outstanding
- 21.5M
- Dividend yield
- —
- 52-week range
- $441.62 – $631.54
Envoy Medical's market cap is $12.71B, based on a share price of $590.53 and 21.5M shares outstanding as of Jun 30, 2025.
Financials
Envoy Medical reported revenue of $241.00K for fiscal 2025, up 7.11% from fiscal 2024.
Envoy Medical reported a net loss of $23.76M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $241.00K | +7.1% | −$23.76M | −9,857.3% | −$1.23 | −$18.38M |
| FY2024ended Dec 31, 2024 | $225.00K | −28.8% | −$20.80M | −9,242.2% | −$1.49 | −$18.93M |
| FY2023ended Dec 31, 2023 | $316.00K | +33.3% | −$29.92M | −9,469.0% | −$2.54 | −$17.24M |
| FY2022ended Dec 31, 2022 | $237.00K | — | −$15.92M | −6,718.6% | −$1.57 | −$9.02M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $51.00K | −$5.98M | −$0.07 |
| Q1 FY2026ended Mar 31, 2026 | $39.00K | −$4.35M | −$0.08 |
| Q4 FY2025ended Dec 31, 2025 | $75.00K | −$6.59M | — |
| Q3 FY2025ended Sep 30, 2025 | $42.00K | −$6.48M | −$0.35 |
| Q2 FY2025ended Jun 30, 2025 | $78.00K | −$5.69M | −$0.32 |
| Q1 FY2025ended Mar 31, 2025 | $46.00K | −$5.00M | −$0.29 |
| Q4 FY2024ended Dec 31, 2024 | $42.00K | −$4.62M | — |
| Q3 FY2024ended Sep 30, 2024 | $56.00K | −$5.96M | −$0.39 |
Company profile
- Name
- Envoy Medical, Inc.
- Ticker
- COCH
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- 4875 White Bear Parkway, White Bear Lake, MN 55110
- Fiscal year ends
- December
- SEC CIK
- 0001840877
Recent SEC filings
- Oct 7, 2026
- Aug 27, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jun 30, 2026
- Jun 25, 2026
- May 22, 2026
- May 18, 2026
Frequently asked questions
What is Envoy Medical's stock price?
Envoy Medical (COCH) closed at $590.53 on Oct 9, 2026, up 0.04% from the previous close of $590.30.
What is Envoy Medical's market cap?
Envoy Medical's market cap is $12.71B, based on a share price of $590.53 and 21.5M shares outstanding as of Jun 30, 2025.
How much revenue does Envoy Medical make?
Envoy Medical reported revenue of $241.00K for fiscal 2025, up 7.11% from fiscal 2024.
Does Envoy Medical pay a dividend?
Envoy Medical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Envoy Medical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures